Curevo is a biotechnology company focused on developing vaccines with improved tolerability and accessibility, currently advancing a shingles vaccine called amezosvatein.

Vicebio Ltd is a biopharmaceutical company developing next-generation multivalent respiratory virus vaccines using proprietary Molecular Clamp technology.

FORE Biotherapeutics is a precision oncology company that focuses on the clinical development of plixorafenib, a novel small-molecule inhibitor for treating BRAF-altered tumors.